Zogenix

Zogenix is committed to developing and commercializing therapies for central nervous system disorders that address specific clinical needs for people living with rare diseases and other CNS disorders such as Dravets, a form of epilepsy where sufferers experience up to 100 fits per day.

Over the 12 month period we appointed;
- General Managers for France, Germany, Italy, Spain & UK
- Medical Affairs Director - London
- Head of EMEA Market Access - London
- Head of EMEA Marketing - London
- Medical Science Liaison - Germany, France, UK and Benelux - 12 Month Contract